Market Place
Sourcing Support
All News #Library
Biotech
SCYNEXIS Complete Acquisition of PXL-770 AMPK Activator for ADPKD
31 Mar 2026 //
GLOBENEWSWIRE
SCYNEXIS Announces $40.0 Million Private Placement
31 Mar 2026 //
GLOBENEWSWIRE
SCYNEXIS Initiates Phase 1 Trial For Intravenous SCY-247
26 Feb 2026 //
GLOBENEWSWIRE
SCYNEXIS Showcases SCY-247`s Antifungal Activity at IMARI
28 Jan 2026 //
GLOBENEWSWIRE
SCYNEXIS Gets FDA (QIDP) & Fast Track Designations For SCY-247
21 Jan 2026 //
GLOBENEWSWIRE
Scynexis Transfers Brexafemme NDA to Gsk
19 Nov 2025 //
GLOBENEWSWIRE
Scynexis Gets Federal Funding for New Fungerp Therapeutics
17 Nov 2025 //
GLOBENEWSWIRE
SCYNEXIS Reveals Q3 2025 Financials & Corporate Update
05 Nov 2025 //
GLOBENEWSWIRE
SCYNEXIS Reports Positive Ph 1 Data for SCY-247 Fungerp
30 Sep 2025 //
GLOBENEWSWIRE
SCYNEXIS Reports Q1 2025 Financial Results and Corporate Update
15 May 2025 //
GLOBENEWSWIRE
SCYNEXIS to Present Data on SCY-247 at ESCMID
08 Apr 2025 //
GLOBENEWSWIRE
SCYNEXIS Initiates Phase 1 Trial of SCY-247 for Fungal Infections
18 Dec 2024 //
GLOBENEWSWIRE
Scynexis Reports Q3 2024 Financials & Corporate Update
06 Nov 2024 //
GLOBENEWSWIRE
SCYNEXIS to Participate in the 2024 Maxim Healthcare Virtual Summit
10 Oct 2024 //
GLOBENEWSWIRE
SCYNEXIS To Present SCY-247 Data At IDWeek 2024
03 Oct 2024 //
GLOBENEWSWIRE
SCYNEXIS Reports Q2 2024 Results And Corporate Update
08 Aug 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.